Novartis Ag (NVS) Research & Development (2009 - 2026)
Novartis Ag (NVS) reported Research & Development of $2.85 billion for Q2 2026, up 4.4% from $2.73 billion a year earlier and up 3.9% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Research & Development (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novartis Ag's Research & Development came in at $11.69 billion, up 13.2% year-over-year; for FY2025, it came in at $11.2 billion, up 11.8% from FY2024.
- Research & Development has a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
- By year, Research & Development came in at $10.02 billion in FY2024 (-11.9%), $11.37 billion in FY2023 (+24.0%), $9.17 billion in FY2022 (+6.1%) and $8.64 billion in FY2021 (-3.8%).
- Five-year quarterly Research & Development spans a low of $2.22 billion in Q4 2022 and a high of $3.93 billion in Q3 2023.
- Year over year, Research & Development has now increased in each of the last five quarters, with growth averaging 4.9% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q3 2023 (growth of 54.4%); the low point was Q3 2024 (a decline of 39.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.74 billion (Q1 2026), $3.16 billion (Q4 2025) and $2.94 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 1.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.85 Bn |
| Mar 31, 2026 | 2.74 Bn |
| Dec 31, 2025 | 3.16 Bn |
| Sep 30, 2025 | 2.94 Bn |
| Jun 30, 2025 | 2.73 Bn |
| Mar 31, 2025 | 2.37 Bn |
| Dec 31, 2024 | 2.84 Bn |
| Sep 30, 2024 | 2.39 Bn |
| Jun 30, 2024 | 2.37 Bn |
| Mar 31, 2024 | 2.42 Bn |
| Dec 31, 2023 | 2.57 Bn |
| Sep 30, 2023 | 3.93 Bn |
| Jun 30, 2023 | 2.30 Bn |
| Mar 31, 2023 | 2.58 Bn |
| Dec 31, 2022 | 2.22 Bn |
| Sep 30, 2022 | 2.54 Bn |
| Jun 30, 2022 | 2.50 Bn |
| Mar 31, 2022 | 2.32 Bn |
| Dec 31, 2021 | 2.41 Bn |
| Sep 30, 2021 | 2.38 Bn |
API Access
Novartis Ag Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();